Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 586Uterine Cervical Neoplasms 497Endometrial Neoplasms 319Breast Neoplasms 140Uterine Cervical Dysplasia 103Neoplasms 102Carcinoma, Ovarian Epithelial 90Fallopian Tube Neoplasms 78Lung Neoplasms 65Colorectal Neoplasms 64Uterine Neoplasms 61Vulvar Neoplasms 56Pancreatic Neoplasms 56Papillomavirus Infections 53Prostatic Neoplasms 52Stomach Neoplasms 49Colonic Neoplasms 47Peritoneal Neoplasms 41Melanoma 39Urinary Bladder Neoplasms 37Carcinoma, Non-Small-Cell Lung 37Esophageal Neoplasms 36Head and Neck Neoplasms 32Pelvic Neoplasms 29Vaginal Neoplasms 28Recurrence 28Rectal Neoplasms 27Ovarian Cysts 27Endometrial Hyperplasia 26Sarcoma 25

Interventions

Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Dysgerminoma × Gynecologic × Clear all
NCT01080521 2018-04-12

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

GOG Foundation

Completed
247 enrolled
Gynecologic

Teratoma, Ovarian, Brenner Tumor, Dysgerminoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡